Additional adjuvant radiotherapy improves survival at 1 year after surgical treatment for pancreatic cancer patients with T(4), N(2) disease, positive resection margin, and receiving adjuvant chemotherapy

BACKGROUND: While adjuvant chemotherapy has been established as standard practice following radical resection of pancreatic ductal adenocarcinoma (PDAC), the role of adjuvant radiation therapy (RT) and which patients may benefit remains unclear. METHODS: This retrospective study included PDAC patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Lili, Xu, Yaolin, Zhou, Yuhong, Zeng, Zhaochong, Fan, Yue, Wang, Dansong, Wu, Wenchuan, Guo, Xi, Lv, Minzhi, Ouyang, Yuxiu, Du, Shisuo, Lou, Wenhui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391548/
https://www.ncbi.nlm.nih.gov/pubmed/37534251
http://dx.doi.org/10.3389/fonc.2023.1109068

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391548/
https://www.ncbi.nlm.nih.gov/pubmed/37534251
http://dx.doi.org/10.3389/fonc.2023.1109068

Ejemplares similares